Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

2020 Imaging Guidelines for Thyroid Nodules and Differentiated Thyroid Cancer: Korean Society of Thyroid Radiology

  • Ji Ye Lee (Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Jung Hwan Baek (Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Eun Ju Ha (Department of Radiology, Ajou University Hospital, Ajou University School of Medicine) ;
  • Jin Yong Sung (Department of Radiology and Thyroid Center, Daerim St. Mary's Hospital) ;
  • Jung Hee Shin (Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Ji-hoon Kim (Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Min Kyoung Lee (Department of Radiology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • So Lyung Jung (Department of Radiology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Young Hen Lee (Department of Radiology, Ansan Hospital, Korea University College of Medicine) ;
  • Hye Shin Ahn (Department of Radiology and Thyroid Center, Chungang University Hospital, Chungang University College of Medicine) ;
  • Jung Hyun Yoon (Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine) ;
  • Yoon Jung Choi (Department of Radiology, Kangbuk Samsung Hospital, Sungkyunkwan University College of Medicine) ;
  • Jeong Seon Park (Department of Radiology, Hanyang University Hospital, Hanyang University College of Medicine) ;
  • Yoo Jin Lee (Department of Radiology, Busan Paik Hospital, Inje University College of Medicine) ;
  • Miyoung Choi (Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency) ;
  • Dong Gyu Na (Department of Radiology, Gangneung Asan Hospital, Ulsan University College of Medicine) ;
  • Korean Society of Thyroid Radiology (KSThR) and Korean Society of Radiology (Korean Society of Thyroid Radiology (KSThR) and Korean Society of Radiology)
  • Received : 2020.05.04
  • Accepted : 2020.10.14
  • Published : 2021.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

Imaging plays a key role in the diagnosis and characterization of thyroid diseases, and the information provided by imaging studies is essential for management planning. A referral guideline for imaging studies may help physicians make reasonable decisions and minimize the number of unnecessary examinations. The Korean Society of Thyroid Radiology (KSThR) developed imaging guidelines for thyroid nodules and differentiated thyroid cancer using an adaptation process through a collaboration between the National Evidence-based Healthcare Collaborating Agency and the working group of KSThR, which is composed of radiologists specializing in thyroid imaging. When evidence is either insufficient or equivocal, expert opinion may supplement the available evidence for recommending imaging. Therefore, we suggest rating the appropriateness of imaging for specific clinical situations in this guideline.

Keywords

Acknowledgement

This study was supported by a grant from the 2019 Clinical Practice Guideline Research Fund by the Korean Society of Radiology & Korean Society of Thyroid Radiology, and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea.

References

  1. Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med 2004;351:1764-1771 https://doi.org/10.1056/NEJMcp031436
  2. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology, thyroid carcinoma. Nccn.org Web site. https://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf. Accessed January 22, 2020
  3. Hoang JK, Langer JE, Middleton WD, Wu CC, Hammers LW, Cronan JJ, et al. Managing incidental thyroid nodules detected on imaging: white paper of the ACR Incidental Thyroid Findings Committee. J Am Coll Radiol 2015;12:143-150 https://doi.org/10.1016/j.jacr.2014.09.038
  4. Expert Panel on Neurological Imaging; Hoang JK, Oldan JD, Mandel SJ, Policeni B, Agarwal V, Burns J, et al. ACR Appropriateness Criteria® thyroid disease. J Am Coll Radiol 2019;16:S300-S314 https://doi.org/10.1016/j.jacr.2019.02.004
  5. Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer "epidemic"--screening and overdiagnosis. N Engl J Med 2014;371:1765-1767 https://doi.org/10.1056/NEJMp1409841
  6. Do KH, Jung SE. Current status of medical radiation exposure in Korea - recent efforts to develop a radiation exposure control system focussed on justification and optimisation. Ann ICRP 2016;45:113-121 https://doi.org/10.1177/0146645316637783
  7. Choi SJ, Jeong WK, Jo AJ, Choi JA, Kim MJ, Lee M, et al. Methodology for developing evidence-based clinical imaging guidelines: joint recommendations by Korean Society of Radiology and National Evidence-Based Healthcare Collaborating Agency. Korean J Radiol 2017;18:208-216 https://doi.org/10.3348/kjr.2017.18.1.208
  8. Moon WJ, Baek JH, Jung SL, Kim DW, Kim EK, Kim JY, et al. Ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations. Korean J Radiol 2011;12:1-14 https://doi.org/10.3348/kjr.2011.12.1.1
  9. Shin JH, Baek JH, Chung J, Ha EJ, Kim JH, Lee YH, et al. Ultrasonography diagnosis and imaging-based management of thyroid nodules: revised Korean Society of Thyroid Radiology consensus statement and recommendations. Korean J Radiol 2016;17:370-395 https://doi.org/10.3348/kjr.2016.17.3.370
  10. Lee YH, Baek JH, Jung SL, Kwak JY, Kim JH, Shin JH; Korean Society of Thyroid Radiology (KSThR); Korean Society of Radiology. Ultrasound-guided fine needle aspiration of thyroid nodules: a consensus statement by the Korean Society of Thyroid Radiology. Korean J Radiol 2015;16:391-401 https://doi.org/10.3348/kjr.2015.16.2.391
  11. Baek JH, Na DG, Lee JH, Jung SL, Kim JH, Sung JY, et al. Core needle biopsy of thyroid nodules: consensus statement and recommendations. Ultrasonography 2013;32:95-102
  12. Na DG, Baek JH, Jung SL, Kim JH, Sung JY, Kim KS, et al. Core needle biopsy of the thyroid: 2016 consensus statement and recommendations from Korean Society of Thyroid Radiology. Korean J Radiol 2017;18:217-237 https://doi.org/10.3348/kjr.2017.18.1.217
  13. Kim JH, Baek JH, Lim HK, Ahn HS, Baek SM, Choi YJ, et al. 2017 thyroid radiofrequency ablation guideline: Korean Society of Thyroid Radiology. Korean J Radiol 2018;19:632-655 https://doi.org/10.3348/kjr.2018.19.4.632
  14. Na DG, Lee JH, Jung SL, Kim JH, Sung JY, Shin JH, et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol 2012;13:117-125 https://doi.org/10.3348/kjr.2012.13.2.117
  15. Hahn SY, Shin JH, Na DG, Ha EJ, Ahn HS, Lim HK, et al. Ethanol ablation of the thyroid nodules: 2018 consensus statement by the Korean Society of Thyroid Radiology. Korean J Radiol 2019;20:609-620 https://doi.org/10.3348/kjr.2018.0696
  16. Steering Committee for Clinical Practice Guideline. Korean appraisal of guidelines for research & evaluation II. Agreetrust.org Web site. http://www.agreetrust.org/wpcontent/uploads/2013/06/AGREE_II_Korean.pdf. Accessed May 15, 2019
  17. American College of Radiology. ACR Appropriateness Criteria® rating round information. Acr.org Web site. https://www.acr.org/-/media/ACR/Files/Appropriateness-Criteria/RatingRoundInfo.pdf. Accessed May 14, 2019
  18. Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR. The RAND/UCLA appropriateness method user's manual (No. RAND/MR-1269-DG-XII/RE). Santa Monica, CA: Rand Corp, 2001
  19. Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedus L, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules - 2016 update. Endocr Pract 2016;22:622-639 https://doi.org/10.4158/EP161208.GL
  20. Ha EJ, Lim HK, Yoon JH, Baek JH, Do KH, Choi M, et al. Primary imaging test and appropriate biopsy methods for thyroid nodules: guidelines by Korean Society of Radiology and National Evidence-Based Healthcare Collaborating Agency. Korean J Radiol 2018;19:623-631 https://doi.org/10.3348/kjr.2018.19.4.623
  21. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26:1-133 https://doi.org/10.1089/thy.2015.0020
  22. Yi KH, Lee EK, Kang HC, Koh Y, Kim SW, Kim IJ, et al. 2016 revised Korean Thyroid Association management guidelines for patients with thyroid nodules and thyroid cancer. Int J Thyroidol 2016;9:59-126 https://doi.org/10.11106/ijt.2016.9.2.59
  23. Perros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard Ba G, et al. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf) 2014;81 Suppl 1:1-122 https://doi.org/10.1111/cen.12515
  24. Brito JP, Gionfriddo MR, Al Nofal A, Boehmer KR, Leppin AL, Reading C, et al. The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis. J Clin Endocrinol Metab 2014;99:1253-1263 https://doi.org/10.1210/jc.2013-2928
  25. Smith-Bindman R, Lebda P, Feldstein VA, Sellami D, Goldstein RB, Brasic N, et al. Risk of thyroid cancer based on thyroid ultrasound imaging characteristics: results of a population-based study. JAMA Intern Med 2013;173:1788-1796 https://doi.org/10.1001/jamainternmed.2013.9245
  26. Solbiati L, Osti V, Cova L, Tonolini M. Ultrasound of thyroid, parathyroid glands and neck lymph nodes. Eur Radiol 2001;11:2411-2424 https://doi.org/10.1007/s00330-001-1163-7
  27. Chiofalo MG, Signoriello S, Fulciniti F, Avenia N, Ristagno S, Lombardi CP, et al. Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective study. Endocrine 2018;61:43-50 https://doi.org/10.1007/s12020-018-1577-5
  28. Lee YH, Kim DW, In HS, Park JS, Kim SH, Eom JW, et al. Differentiation between benign and malignant solid thyroid nodules using an US classification system. Korean J Radiol 2011;12:559-567 https://doi.org/10.3348/kjr.2011.12.5.559
  29. Mandel SJ. Diagnostic use of ultrasonography in patients with nodular thyroid disease. Endocr Pract 2004;10:246-252 https://doi.org/10.4158/EP.10.3.246
  30. Cesur M, Corapcioglu D, Bulut S, Gursoy A, Yilmaz AE, Erdogan N, et al. Comparison of palpation-guided fine-needle aspiration biopsy to ultrasound-guided fine-needle aspiration biopsy in the evaluation of thyroid nodules. Thyroid 2006;16:555-561 https://doi.org/10.1089/thy.2006.16.555
  31. Hambly NM, Gonen M, Gerst SR, Li D, Jia X, Mironov S, et al. Implementation of evidence-based guidelines for thyroid nodule biopsy: a model for establishment of practice standards. AJR Am J Roentgenol 2011;196:655-660 https://doi.org/10.2214/AJR.10.4577
  32. Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L. European Thyroid Association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS. Eur Thyroid J 2017;6:225-237 https://doi.org/10.1159/000478927
  33. Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol 2017;14:587-595 https://doi.org/10.1016/j.jacr.2017.01.046
  34. Shetty SK, Maher MM, Hahn PF, Halpern EF, Aquino SL. Significance of incidental thyroid lesions detected on CT: correlation among CT, sonography, and pathology. AJR Am J Roentgenol 2006;187:1349-1356 https://doi.org/10.2214/AJR.05.0468
  35. Hoang JK, Branstetter BF 4th, Gafton AR, Lee WK, Glastonbury CM. Imaging of thyroid carcinoma with CT and MRI: approaches to common scenarios. Cancer Imaging 2013;13:128-139 https://doi.org/10.1102/1470-7330.2013.0013
  36. Shah MD, Hall FT, Eski SJ, Witterick IJ, Walfish PG, Freeman JL. Clinical course of thyroid carcinoma after neck dissection. Laryngoscope 2003;113:2102-2107 https://doi.org/10.1097/00005537-200312000-00008
  37. Wang TS, Dubner S, Sznyter LA, Heller KS. Incidence of metastatic well-differentiated thyroid cancer in cervical lymph nodes. Arch Otolaryngol Head Neck Surg 2004;130:110-113 https://doi.org/10.1001/archotol.130.1.110
  38. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050-1057; discussion 1057-1058
  39. Yi KH, Lee EK, Kang HC, Koh Y, Kim SW, Kim IJ, et al. 2016 revised Korean Thyroid Association management guidelines for patients with thyroid nodules and thyroid cancer. Int J Thyroidol 2016;9:59-126 https://doi.org/10.11106/ijt.2016.9.2.59
  40. Yeh MW, Bauer AJ, Bernet VA, Ferris RL, Loevner LA, Mandel SJ, et al. American Thyroid Association statement on preoperative imaging for thyroid cancer surgery. Thyroid 2015;25:3-14 https://doi.org/10.1089/thy.2014.0096
  41. Pacini F, Basolo F, Bellantone R, Boni G, Cannizzaro MA, De Palma M, et al. Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies. J Endocrinol Invest 2018;41:849-876 https://doi.org/10.1007/s40618-018-0884-2
  42. Eun NL, Son EJ, Kim JA, Gweon HM, Kang JH, Youk JH. Comparison of the diagnostic performances of ultrasonography, CT and fine needle aspiration cytology for the prediction of lymph node metastasis in patients with lymph node dissection of papillary thyroid carcinoma: a retrospective cohort study. Int J Surg 2018;51:145-150 https://doi.org/10.1016/j.ijsu.2017.12.036
  43. Jiang HJ, Wu CW, Chiang FY, Chiou HC, Chen IJ, Hsiao PJ. Reliable sonographic features for nodal thyroglobulin to diagnose recurrent lymph node metastasis from papillary thyroid carcinoma. Clin Otolaryngol 2018 Mar [Epub]. https://doi.org/10.1111/coa.13103
  44. Leboulleux S, Girard E, Rose M, Travagli JP, Sabbah N, Caillou B, et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab 2007;92:3590-3594 https://doi.org/10.1210/jc.2007-0444
  45. O'Connell K, Yen TW, Quiroz F, Evans DB, Wang TS. The utility of routine preoperative cervical ultrasonography in patients undergoing thyroidectomy for differentiated thyroid cancer. Surgery 2013;154:697-701; discussion 701-703 https://doi.org/10.1016/j.surg.2013.06.040
  46. Rosario PW, de Faria S, Bicalho L, Alves MF, Borges MA, Purisch S, et al. Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma. J Ultrasound Med 2005;24:1385-1389 https://doi.org/10.7863/jum.2005.24.10.1385
  47. Shimamoto K, Satake H, Sawaki A, Ishigaki T, Funahashi H, Imai T. Preoperative staging of thyroid papillary carcinoma with ultrasonography. Eur J Radiol 1998;29:4-10 https://doi.org/10.1016/S0720-048X(97)00184-8
  48. Solorzano CC, Carneiro DM, Ramirez M, Lee TM, Irvin GL 3rd. Surgeon-performed ultrasound in the management of thyroid malignancy. Am Surg 2004;70:576-580; discussion 580-582 https://doi.org/10.1177/000313480407000703
  49. Stulak JM, Grant CS, Farley DR, Thompson GB, van Heerden JA, Hay ID, et al. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg 2006;141:489-494; discussion 494-496 https://doi.org/10.1001/archsurg.141.5.489
  50. Lee CY, Kim SJ, Ko KR, Chung KW, Lee JH. Predictive factors for extrathyroidal extension of papillary thyroid carcinoma based on preoperative sonography. J Ultrasound Med 2014;33:231-238 https://doi.org/10.7863/ultra.33.2.231
  51. Kwak JY, Kim EK, Youk JH, Kim MJ, Son EJ, Choi SH, et al. Extrathyroid extension of well-differentiated papillary thyroid microcarcinoma on US. Thyroid 2008;18:609-614 https://doi.org/10.1089/thy.2007.0345
  52. Choi JS, Chung WY, Kwak JY, Moon HJ, Kim MJ, Kim EK. Staging of papillary thyroid carcinoma with ultrasonography: performance in a large series. Ann Surg Oncol 2011;18:3572-3578 https://doi.org/10.1245/s10434-011-1783-3
  53. Park JS, Son KR, Na DG, Kim E, Kim S. Performance of preoperative sonographic staging of papillary thyroid carcinoma based on the sixth edition of the AJCC/UICC TNM classification system. AJR Am J Roentgenol 2009;192:66-72 https://doi.org/10.2214/AJR.07.3731
  54. Moon SJ, Kim DW, Kim SJ, Ha TK, Park HK, Jung SJ. Ultrasound assessment of degrees of extrathyroidal extension in papillary thyroid microcarcinoma. Endocr Pract 2014;20:1037-1043 https://doi.org/10.4158/EP14016.OR
  55. Kim SS, Lee BJ, Lee JC, Kim SJ, Lee SH, Jeon YK, et al. Preoperative ultrasonographic tumor characteristics as a predictive factor of tumor stage in papillary thyroid carcinoma. Head Neck 2011;33:1719-1726 https://doi.org/10.1002/hed.21658
  56. Kuo EJ, Thi WJ, Zheng F, Zanocco KA, Livhits MJ, Yeh MW. Individualizing surgery in papillary thyroid carcinoma based on a detailed sonographic assessment of extrathyroidal extension. Thyroid 2017;27:1544-1549 https://doi.org/10.1089/thy.2017.0457
  57. Zhao H, Li H. Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: diagnosis of central and lateral compartment nodal metastases. Eur J Radiol 2019;112:14-21 https://doi.org/10.1016/j.ejrad.2019.01.006
  58. Boi F, Baghino G, Atzeni F, Lai ML, Faa G, Mariotti S. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies. J Clin Endocrinol Metab 2006;91:1364-1369 https://doi.org/10.1210/jc.2005-1705
  59. Chung J, Kim EK, Lim H, Son EJ, Yoon JH, Youk JH, et al. Optimal indication of thyroglobulin measurement in fine-needle aspiration for detecting lateral metastatic lymph nodes in patients with papillary thyroid carcinoma. Head Neck 2014;36:795-801 https://doi.org/10.1002/hed.23371
  60. Frasoldati A, Toschi E, Zini M, Flora M, Caroggio A, Dotti C, et al. Role of thyroglobulin measurement in fine-needle aspiration biopsies of cervical lymph nodes in patients with differentiated thyroid cancer. Thyroid 1999;9:105-111 https://doi.org/10.1089/thy.1999.9.105
  61. Grani G, Fumarola A. Thyroglobulin in lymph node fine-needle aspiration washout: a systematic review and meta-analysis of diagnostic accuracy. J Clin Endocrinol Metab 2014;99:1970-1982 https://doi.org/10.1210/jc.2014-1098
  62. Moon JH, Kim YI, Lim JA, Choi HS, Cho SW, Kim KW, et al. Thyroglobulin in washout fluid from lymph node fine-needle aspiration biopsy in papillary thyroid cancer: largescale validation of the cutoff value to determine malignancy and evaluation of discrepant results. J Clin Endocrinol Metab 2013;98:1061-1068 https://doi.org/10.1210/jc.2012-3291
  63. Pacini F, Fugazzola L, Lippi F, Ceccarelli C, Centoni R, Miccoli P, et al. Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer. J Clin Endocrinol Metab 1992;74:1401-1404
  64. Pak K, Suh S, Hong H, Cheon GJ, Hahn SK, Kang KW, et al. Diagnostic values of thyroglobulin measurement in fine-needle aspiration of lymph nodes in patients with thyroid cancer. Endocrine 2015;49:70-77 https://doi.org/10.1007/s12020-014-0410-z
  65. Snozek CL, Chambers EP, Reading CC, Sebo TJ, Sistrunk JW, Singh RJ, et al. Serum thyroglobulin, high-resolution ultrasound, and lymph node thyroglobulin in diagnosis of differentiated thyroid carcinoma nodal metastases. J Clin Endocrinol Metab 2007;92:4278-4281 https://doi.org/10.1210/jc.2007-1075
  66. Lee Y, Kim JH, Baek JH, Jung SL, Park SW, Kim J, et al. Value of CT added to ultrasonography for the diagnosis of lymph node metastasis in patients with thyroid cancer. Head Neck 2018;40:2137-2148 https://doi.org/10.1002/hed.25202
  67. Suh CH, Baek JH, Choi YJ, Lee JH. Performance of CT in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid cancer: a systematic review and meta-analysis. AJNR Am J Neuroradiol 2017;38:154-161 https://doi.org/10.3174/ajnr.A4967
  68. Lesnik D, Cunnane ME, Zurakowski D, Acar GO, Ecevit C, Mace A, et al. Papillary thyroid carcinoma nodal surgery directed by a preoperative radiographic map utilizing CT scan and ultrasound in all primary and reoperative patients. Head Neck 2014;36:191-202 https://doi.org/10.1002/hed.23277
  69. Hoang JK, Vanka J, Ludwig BJ, Glastonbury CM. Evaluation of cervical lymph nodes in head and neck cancer with CT and MRI: tips, traps, and a systematic approach. AJR Am J Roentgenol 2013;200:W17-25 https://doi.org/10.2214/AJR.12.8960
  70. Cho SJ, Suh CH, Baek JH, Chung SR, Choi YJ, Lee JH. Diagnostic performance of CT in detection of metastatic cervical lymph nodes in patients with thyroid cancer: a systematic review and meta-analysis. Eur Radiol 2019;29:4635-4647 https://doi.org/10.1007/s00330-019-06036-8
  71. Cho SJ, Suh CH, Baek JH, Chung SR, Choi YJ, Lee JH. Diagnostic performance of MRI to detect metastatic cervical lymph nodes in patients with thyroid cancer: a systematic review and meta-analysis. Clin Radiol 2020;75:562.e1-562.e10 https://doi.org/10.1016/j.crad.2020.03.025
  72. Choi JY, Choi YS, Park YH, Kim JH. Experience and analysis of level VII cervical lymph node metastases in patients with papillary thyroid carcinoma. J Korean Surg Soc 2011;80:307-312 https://doi.org/10.4174/jkss.2011.80.5.307
  73. Seo YL, Yoon DY, Lim KJ, Cha JH, Yun EJ, Choi CS, et al. Locally advanced thyroid cancer: can CT help in prediction of extrathyroidal invasion to adjacent structures? AJR Am J Roentgenol 2010;195:W240-244 https://doi.org/10.2214/AJR.09.3965
  74. Takashima S, Takayama F, Wang J, Kobayashi S, Kadoya M. Using MR imaging to predict invasion of the recurrent laryngeal nerve by thyroid carcinoma. AJR Am J Roentgenol 2003;180:837-842 https://doi.org/10.2214/ajr.180.3.1800837
  75. Wang J, Takashima S, Matsushita T, Takayama F, Kobayashi T, Kadoya M. Esophageal invasion by thyroid carcinomas: prediction using magnetic resonance imaging. J Comput Assist Tomogr 2003;27:18-25 https://doi.org/10.1097/00004728-200301000-00004
  76. Wang JC, Takashima S, Takayama F, Kawakami S, Saito A, Matsushita T, et al. Tracheal invasion by thyroid carcinoma: prediction using MR imaging. AJR Am J Roentgenol 2001;177:929-936 https://doi.org/10.2214/ajr.177.4.1770929
  77. Lee YS, Son EJ, Chang HS, Chung WY, Nam KH, Park CS. Computed tomography is useful for preoperative identification of nonrecurrent laryngeal nerve in thyroid cancer patients. Otolaryngol Head Neck Surg 2011;145:204-207 https://doi.org/10.1177/0194599811406670
  78. Haq M, Harmer C. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol (Oxf) 2005;63:87-93 https://doi.org/10.1111/j.1365-2265.2005.02304.x
  79. Leite AK, Kulcsar MA, de Godoi Cavalheiro B, de Mello ES, Alves VA, Cernea CR, et al. Death related to pulmonary metastasis in patients with differentiated thyroid cancer. Endocr Pract 2017;23:72-78 https://doi.org/10.4158/EP161431.OR
  80. Vuong HG, Duong UNP, Pham TQ, Tran HM, Oishi N, Mochizuki K, et al. Clinicopathological risk factors for distant metastasis in differentiated thyroid carcinoma: a meta-analysis. World J Surg 2018;42:1005-1017 https://doi.org/10.1007/s00268-017-4206-1
  81. Lee YS, Lim YS, Lee JC, Wang SG, Kim IJ, Son SM, et al. Clinical implications of bilateral lateral cervical lymph node metastasis in papillary thyroid cancer: a risk factor for lung metastasis. Ann Surg Oncol 2011;18:3486-3492 https://doi.org/10.1245/s10434-011-1763-7
  82. Momesso DP, Tuttle RM. Update on differentiated thyroid cancer staging. Endocrinol Metab Clin North Am 2014;43:401-421 https://doi.org/10.1016/j.ecl.2014.02.010
  83. Pacini F, Molinaro E, Castagna MG, Agate L, Elisei R, Ceccarelli C, et al. Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 2003;88:3668-3673 https://doi.org/10.1210/jc.2002-021925
  84. Torlontano M, Crocetti U, Augello G, D'Aloiso L, Bonfitto N, Varraso A, et al. Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy. J Clin Endocrinol Metab 2006;91:60-63 https://doi.org/10.1210/jc.2005-1185
  85. Lee JI, Chung YJ, Cho BY, Chong S, Seok JW, Park SJ. Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma. Surgery 2013;153:828-835 https://doi.org/10.1016/j.surg.2012.12.008
  86. Lepoutre-Lussey C, Maddah D, Golmard JL, Russ G, Tissier F, Tresallet C, et al. Post-operative neck ultrasound and risk stratification in differentiated thyroid cancer patients with initial lymph node involvement. Eur J Endocrinol 2014;170:837-846 https://doi.org/10.1530/EJE-13-0888
  87. Leenhardt L, Erdogan MF, Hegedus L, Mandel SJ, Paschke R, Rago T, et al. 2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. Eur Thyroid J 2013;2:147-159 https://doi.org/10.1159/000354537
  88. Nascimento C, Borget I, Al Ghuzlan A, Deandreis D, Chami L, Travagli JP, et al. Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level. Endocr Relat Cancer 2011;18:R29-40 https://doi.org/10.1677/ERC-10-0292
  89. Schlumberger M, Pacini F, Wiersinga WM, Toft A, Smit JW, Sanchez Franco F, et al. Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice. Eur J Endocrinol 2004;151:539-548 https://doi.org/10.1530/eje.0.1510539
  90. Grani G, Ramundo V, Falcone R, Lamartina L, Montesano T, Biffoni M, et al. Thyroid cancer patients with no evidence of disease: the need for repeat neck ultrasound. J Clin Endocrinol Metab 2019;104:4981-4989 https://doi.org/10.1210/jc.2019-00962
  91. Ahn JE, Lee JH, Yi JS, Shong YK, Hong SJ, Lee DH, et al. Diagnostic accuracy of CT and ultrasonography for evaluating metastatic cervical lymph nodes in patients with thyroid cancer. World J Surg 2008;32:1552-1558 https://doi.org/10.1007/s00268-008-9588-7
  92. Choi JS, Kim J, Kwak JY, Kim MJ, Chang HS, Kim EK. Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT. AJR Am J Roentgenol 2009;193:871-878 https://doi.org/10.2214/AJR.09.2386
  93. Spate V, Morris J, Nichols T, Baskett C, Mason M, Horsman T, et al. Longitudinal study of iodine in toenails following IV administration of an iodine-containing contrast agent. J Radioanal Nucl Chem 1998;236:71-77 https://doi.org/10.1007/BF02386320
  94. Sohn SY, Choi JH, Kim NK, Joung JY, Cho YY, Park SM, et al. The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment. Thyroid 2014;24:872-877 https://doi.org/10.1089/thy.2013.0238
  95. Mishra A, Pradhan PK, Gambhir S, Sabaretnam M, Gupta A, Babu S. Preoperative contrast-enhanced computerized tomography should not delay radioiodine ablation in differentiated thyroid carcinoma patients. J Surg Res 2015;193:731-737 https://doi.org/10.1016/j.jss.2014.07.065
  96. Tala Jury HP, Castagna MG, Fioravanti C, Cipri C, Brianzoni E, Pacini F. Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients. J Clin Endocrinol Metab 2010;95:230-237 https://doi.org/10.1210/jc.2009-1624